Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy
Current Oncology · 2024
DOI: 10.3390/curroncol31050180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Matthias Schneider und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Ventriculoperitoneal Shunt, Meningeal Carcinomatosis, Hydrocephalus, Injections, Spinal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Therapeutic management of patients with leptomeningeal carcinomatosis (LC) may require treatment of concomitant hydrocephalus (HC) in addition to intrathecal chemotherapy (ITC). Ventriculoperitoneal shunts (VPS) equipped with a valve for manual deactivation of shunt function and a concomitant reservoir for application of ITC pose an elegant solution to both problems. The present study evaluates indication, feasibility, and safety of such a modified shunt/reservoir design (mS/R). All patients with LC aged ≥ 18 years who had undergone mS/R implantation between 2013 and 2020 at the authors’ institution were further analyzed. ITC was indicated following the recommendation of the neuro-oncological tumor board and performed according to a standardized protocol. Sixteen patients with LC underwent mS/R implantation for subsequent ITC and concomitant treatment of HC. Regarding HC-related clinical symptoms, 69% of patients preoperatively exhibited lethargy, 38% cognitive impairment, and 38% (additional) visual disturbances. Postoperatively, 86% of patients achieved subjective improvement of HC-related symptoms. Overall, postoperative complications occurred in three patients (19%). No patient encountered cancer treatment-related complications. The present study describes a combination procedure consisting of a standard VPS-system and a standard reservoir for patients suffering from LC and HC. No cancer treatment-related complications occurred, indicating straightforward handling and thus safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany.
- Division of Clinical Neuro-Oncology, Department of Neurology, University Hospital Bonn, 53127 Bonn, Germany.
ORCID-Profile: Matthias Schneider, Anna-Laura Potthoff, Valeri Borger, Patrick Schuss
Zitieren
APA
Schneider, M., Wispel, C., Potthoff, A. L., Heimann, M., Borger, V., Schaub, C., Herrlinger, U., Vatter, H., Schuss, P., & Schäfer, N. (2024). Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy. Current Oncology. https://doi.org/10.3390/curroncol31050180
Vancouver
Schneider M, Wispel C, Potthoff AL, Heimann M, Borger V, Schaub C, et al. Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy. Current Oncology. 2024. doi:10.3390/curroncol31050180
BibTeX
@article{Schneider2024,
author = {Schneider, Matthias and Wispel, Christian and Potthoff, Anna-Laura and Heimann, Muriel and Borger, Valeri and Schaub, Christina and Herrlinger, Ulrich and Vatter, Hartmut and Schuss, Patrick and Schäfer, Niklas},
title = {Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31050180}
}
EUVIMED